Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected Children
NCT00002219 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 36
Last updated 2005-06-24
Summary
The purpose of this study is to see if it is safe and effective to give adefovir (a new anti-HIV drug) plus nelfinavir to HIV-infected children who are already receiving other anti-HIV medications.
Conditions
- HIV Infections
Interventions
- DRUG
-
Nelfinavir mesylate
- DRUG
-
Levocarnitine
- DRUG
-
Adefovir dipivoxil
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 3 Months
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
A Phase I Multiple Dose Pharmacokinetic Study of Nevirapine Extended Release (XR) in HIV-1 Infected Children.
NCT00905489 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children
NCT00000865 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety and Effectiveness of Zidovudine Plus Lamivudine, Used With and Without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 Drugs
NCT00002391 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV
NCT02016924 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Safety, Tolerability, and Anti-HIV Activity of DMP 266 (Efavirenz) in Combination With Nelfinavir in HIV-Positive Children
NCT00000893 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 Years
NCT00799864 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children
NCT00000901 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Drug Treatment of Pediatric HIV Infection
NCT00001818 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and Stavudine
NCT00001688 ·Status: COMPLETED ·Phase: PHASE2
-
Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV
NCT00084058 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination With Zidovudine in HIV-1 Infected Children
NCT00001066 ·Status: COMPLETED ·Phase: PHASE2
-
Blood Levels of Anti-HIV Drugs Used in Combination Regimens in HIV Infected Children
NCT00260078 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs
NCT00002379 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children
NCT00528957 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Effectiveness of Giving Two Nucleoside Reverse Transcriptase Inhibitors Alone or in Combination With 141W94 to HIV-Infected Children Who Have Never Received Protease Inhibitors
NCT00002193 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment
NCT00002419 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Stavudine Used Alone or in Combination With Didanosine in HIV-Infected Children
NCT00000851 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Sudy of Atazanavir Boosted With Ritonavir in the Treatment of HIV Infection in Pediatric Patients
NCT01691794 ·Status: COMPLETED ·Phase: PHASE4
-
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3
NCT00002161 ·Status: COMPLETED ·Phase: NA
-
A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses
NCT00001108 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparative Study of Combination Antiretroviral Therapy in Children and Adolescents With Advanced HIV Disease
NCT00000814 ·Status: COMPLETED ·Phase: PHASE1
-
Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen
NCT00000903 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety and Effectiveness of Two Forms of Saquinavir Combined With Other Anti-HIV Drugs in HIV-Infected Infants and Children
NCT00002380 ·Status: COMPLETED ·Phase: PHASE1
-
Two Part Study to Evaluate Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir Administered With a PI/r Background Regimen for ARV Treatment-Experienced Pediatric Participants
NCT01923311 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of Age
NCT03760458 ·Status: COMPLETED ·Phase: PHASE1/PHASE2